Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Risperidone + Haloperidol in Schizophrenia
NCT00998608Phase 4Terminated
- Sponsor
- Kaohsiung Municipal Kai-Suan Psychiatric Hospital
- Start
- Aug 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Risperidone Monotherapy with Risperidone + Haloperidol (2 arms). Primary endpoint: Positive and Negative Syndrome Scale Total Score at 6 weeks. Started Aug 2007; status: terminated.
02
Drugs
risperidonehaloperidol
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00998608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00998608.